“A stimulating and exciting look at how we got to the present state of health care and where we can potentially go. A unique perspective and a great read.”
David Lester, Ph.D., President, ITHW Inc.; formerly Director, Human Health Technologies, Pfizer Inc.
“The explosion of new knowledge in the biosciences will raise important challenges for our social, ethical, and economic thinking. The Schoemakers have given us an incredibly useful book to stimulate that thinking. One could not ask for a better guidebook to an exciting if challenging future.”
Professor Arthur L. Caplan, Director of the Center for Bioethics and Hart Professor, University of Pennsylvania
“What a fascinating book! The authors have really mastered all the aspects (social, human, scientific, and business) of the biomedical revolution that is taking place this century. Awesome.”
Giancarlo Barolat,M.D., Director, Barolat Neuroscience, Presbyterian St. Luke Medical Center, Denver; formerly Professor of Neurosurgery at Thomas Jefferson University, Philadelphia
“Wonderfully comprehensive, yet still digestible for non-scientists. Wish I had this book when we examined some health care innovation opportunities at GE; it would have provided a great foundation for the team.”
Patia McGrath, Global Director - Innovation and Strategic Connections, Corporate Marketing, General Electric
The key scientific discoveries of the 21st century are coming from the biosciences. These discoveries will impact our lives in ways we can only begin to imagine. Now, two leading experts will help you imagine those impacts--and prepare for them. Paul and Joyce Schoemaker preview the research innovations most likely to emerge in the coming years and reveal what they’re likely to mean for everything from human longevity to the health of society, from bioterrorism to personalized medicine.
Writing for every interested citizen and consumer, the Schoemakers illuminate the hottest technologies and most controversial issues associated with contemporary biotechnology--including stem cells, cloning, pharmacogenetics, DNA chips, proteomics, gene therapy, and much more. Then, drawing on Paul Schoemaker’s unsurpassed experience helping global organizations prepare for the future, the authors sketch multiple long-term scenarios for the biosciences…and reveal how they will impact your health, family, career, and the society you live in.
• How long will you live? How long can you live?
Beyond 100: breakthroughs made, breakthroughs yet to come
• New business opportunities for the age of biosciences
The future of pharmaceuticals, medical devices, diagnostics, disease management, and prevention
• The economics, politics, and technology of the bioscience revolution
What’s driving the biosciences--and what could halt them dead in their tracks
• To 2025 and beyond: powerful scenarios and what they mean
Making sense of the age of biosciences--so you can make better decisions for you and your family
Paul J. H. Schoemaker, Ph.D. is Research Director of the Mack Center for Technological Innovation at The Wharton School, where he teaches strategy and decision making. Dr. Schoemaker is also the founder and chairman of Decision Strategies International, Inc., a consulting and training firm specializing in strategic planning and executive development. He has written more than 100 academic and applied papers as well as coauthored numerous books, including Decision Traps, Wharton on Managing Emerging Technologies, Winning Decisions, Profiting from Uncertainty, and Peripheral Vision. He serves on multiple boards.
Joyce A. Schoemaker, Ph.D. has conducted basic research in microbiology and molecular genetics at the University of Chicago and taught microbiology at Villanova University. She has held positions in research and management at several biotechnology companies, including Celltech in London, and has published numerous scientific articles in biology. She is coauthor of Healthy Homes, Healthy Kids: Protecting Your Children From Everyday Environmental Hazards. Dr. Schoemaker has a long-standing interest in environmental issues as well as the emerging biosciences.